Lack of Kcnn4 improves mucociliary clearance in muco-obstructive lung disease

Area of Science:

• Pulmonary Medicine
• Ion Channel Physiology
• Respiratory Disease Research

Background:

• Airway mucociliary clearance (MCC) is crucial for lung defense, relying on airway surface liquid volume, ciliary beating, and mucus properties.
• Sodium absorption and anion secretion critically regulate MCC, with impaired function leading to muco-obstructive diseases.
• The calcium-activated potassium channel KCa3.1 (Kcnn4) is implicated in ion secretion, but its specific role in airway epithelium and MCC requires further elucidation.

Purpose of the Study:

• To investigate the role of the KCa3.1 channel (Kcnn4) in airway epithelial function and mucociliary clearance (MCC).
• To evaluate the therapeutic potential of KCa3.1 inhibition in a mouse model of muco-obstructive lung disease.

Main Methods:

• Utilized genetically engineered mice with Kcnn4 deletion or silencing.
• Assessed KCa3.1 inhibition effects on sodium absorption in mouse and human airway epithelium.
• Evaluated MCC function ex vivo and in vivo, alongside mucus properties and lung pathology in disease models.

Main Results:

• KCa3.1 inhibition significantly reduced sodium absorption in both mouse and human airway epithelia.
• Genetic deletion of Kcnn4 enhanced ciliary beating frequency and MCC.
• Kcnn4 silencing in a muco-obstructive lung disease model improved MCC, reduced sodium absorption, mucus adhesion, neutrophil infiltration, and emphysema.

Conclusions:

• KCa3.1 channel activity is a key regulator of sodium absorption and MCC in the airway epithelium.
• KCa3.1 inhibition effectively attenuated muco-obstructive lung disease features in mice.
• Modulating K+ channels, specifically KCa3.1, presents a promising therapeutic strategy for muco-obstructive lung diseases.